What does Aspyra Inc. do?

Aspyra Inc. (APYI) operates in the Medical - Healthcare Information Services industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

What is APYI's market cap?

Aspyra Inc. (APYI) has a market capitalization of approximately $34, as of August 26, 2026, based on the most recent share price and shares outstanding.

Does APYI pay a dividend?

No — Aspyra Inc. (APYI) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.

Aspyra Inc. (APYI) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.

APYI

Aspyra Inc.

OTC·Medical, Healthcare Information Services · Healthcare

$0.00$0.00+0.00%

Market cap$34.00·Market closed·Aug 26 8:00 PM UTC

Price Chart

$0.00+$0.00 (+0.00%)today

−99.43%CAGR −64.42%

Select date range

FromTo

Jan 2, 1985Aug 27, 2021 → Aug 27, 2026· 5.0 yrsAug 27, 2026

Key Metrics

APYI does not currently pay a dividend.

EarningsEarnings Tab

EPS (FWD)—

P/E Ratio (FWD)—

EPS Growth (1Y)—

EPS Growth (3Y)—

EPS Growth (5Y)—

Next Earnings Date—

Last Report Date—

Reported vs Estimate—

Earnings Surprise—

FinancialsFinancials Tab

Revenue$7.75M

Net Income−$6.64M

Net Margin−85.7%

Operating Cash Flow−$1.94M

Capital Expenditures$440.76K

Free Cash Flow−$2.38M

Return on Equity−158.1%

Return on Invested Capital11.6%

Net Debt$4.03M

Value Graph

PRO

See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.

Click below to see what's inside, then upgrade to unlock for APYI and 80,000+ other tickers.

EPS · Price vs. Fair Value Price Fair

Income Statement Flow

PRO

See exactly how APYI's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.

The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for APYI and 80,000+ other tickers.

About Aspyra Inc.

Aspyra Inc. specializes in healthcare solutions, delivering essential products and services to both the laboratory and medical imaging industries. The company provides meticulously crafted workflow systems, which encompass software, connectivity tools, physical hardware, and expert support services. These solutions are adopted by a diverse range of healthcare organizations, such as specialized and reference laboratories, medical clinics, hospitals, diagnostic imaging centers, and orthopedic practices. Established in 1978, the enterprise initially operated as Creative Computer Applications…

CEO: Gary W. Bennett
Sector: Healthcare
Industry: Medical - Healthcare Information Services
Exchange: OTC
Employees: 69
Website: www.aspyra.com

Peers

Peers Tab

ABMT

Advanced BioMedical Technologies Inc.

FOXO Technologies Inc.

Cap

$899.7K

Latest News

News Tab

No recent news available.

Frequently Asked Questions About APYI

What does Aspyra Inc. do?: Aspyra Inc. (APYI) operates in the Medical - Healthcare Information Services industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.
What is APYI's market cap?: Aspyra Inc. (APYI) has a market capitalization of approximately $34, as of August 26, 2026, based on the most recent share price and shares outstanding.
Does APYI pay a dividend?: No — Aspyra Inc. (APYI) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.
Is APYI profitable?: Aspyra Inc. (APYI) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.